Negative experiences and donor return: an examination of the role of asking for something different by Masser, Barbara et al.
This is the author’s version of a work that was submitted/accepted for pub-
lication in the following source:
Masser, Barbara M., Bove, Liliana L., White, Katherine M., & Bagot, Kath-
leen L.
(2016)
Negative experiences and donor return: An examination of the role of ask-
ing for something different.
Transfusion, 56(3), pp. 605-613.
This file was downloaded from: https://eprints.qut.edu.au/94093/
c© 2015 AABB
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
https://doi.org/10.1111/trf.13390
	 1
Negative experiences and donor return:  An examination of the role of asking for something 
different. 
 
Barbara M Masser1,2, Liliana L. Bove3, Katherine M. White4, &, Kathleen L. Bagot5,6  
 
1 School of Psychology, McElwain Building, The University of Queensland, St Lucia, 
Queensland 4072, Australia 
2 Research & Development, Australian Red Cross Blood Service, Brisbane, Australia 
E: b.masser@psy.uq.edu.au 
	
3 Department of Management and Marketing, University of Melbourne, 198 Berkeley Street, 
Melbourne, Victoria 3010, Australia 
E: lbove@unimelb.edu.au 
 
4 School of Psychology and Counselling, Queensland University of Technology, Victoria 
Park Road, Kelvin Grove. Brisbane, Queensland 4059, Australia	
E: km.white@qut.edu.au	
	
 
5 Public Health, The Florey Institute of Neuroscience and Mental Health, 245 Burgundy 
Street, Heidelberg, Victoria 3084, Australia 
6 Translational Public Health and Evaluation Division, School of Clinical Sciences, Faculty of 
Medicine, Nursing and Health Science, Monash University, Victoria 3800, Australia 
E: kathleen.bagot@florey.edu.au 
 
	 2
Corresponding Author 
Associate Professor Barbara Masser 
School of Psychology, McElwain Building, The University of Queensland, St Lucia, QLD 
4072, Australia 
E: b.masser@psy.uq.edu.au, Phone: +61 7 3365 6373, Fax +61 7 3365 4466  
 
Running Head: Negative experiences and donor return 
 
Conflict of Interest: There are no conflicts of interest for any of the authors. 
 
Word Count: 3988 words (excluding abstract, tables, references)  
 
 
 
 
 
	 3
 
Abstract  
Background 
Negative donation experiences, including vasovagal reactions, deter donor retention. 
However, whether this deterrence effect varies as a function of whole blood (WB) donation 
history and requests to donate the same or a different product remains unclear. 
Study Design and Methods 
The responses of 894 eligible WB donors who had been approached to convert to 
plasmapheresis and 954 eligible first-time plasmapheresis donors who had been surveyed on 
their last donation experience and their intention to donate plasma were considered. This 
information was matched with individual vasovagal reaction records, deferral category, WB 
donation history, and subsequent donation behavioral data obtained from the Blood 
Collection Agency (BCA).  
Results 
Path analysis indicated that the application of a deferral and an officially recorded vasovagal 
reaction decreased donors’ intentions to continue plasmapheresis donation, but had no effect 
on WB donors’ intentions to convert to plasmapheresis. Consistent with past findings, 
vasovagal reactions occurred more frequently with female and inexperienced donors. 
Conclusion 
Experiencing vasovagal reactions and deferrals may not universally deter donors from 
continuing to donate. Rather, the offer to convert to another form of donation – in this 
instance, plasmapheresis – after experiencing a negative donation event while donating WB 
may be sufficient to eliminate the deterrence effect on retention. 
 
Keywords Donors, whole blood, plasmapheresis, retention, adverse events, vasovagal 
reactions, deferrals
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Donors can experience three types of negative events during or after donation that deter them 
from donating again. The first is the application of a deferral, which occurs when a donor is 
assessed as ineligible to donate.  Deferrals are applied for a variety of behavioral and medical 
reasons, vary in duration (from one day to permanent) and are applied to protect either the 
recipient or the donor [1].  As the application of a deferral prevents the donor from donating 
for a period of time, including when presenting to donate, this may cause the donor 
inconvenience and frustration. Deferrals are well documented to have a consistent negative 
impact on within panel retention [1-3] and their effects, without intervention, typically persist 
past the duration of the mandatory deferral period [1-3]. 
 
The second type of negative event occurs during or post donation and takes the form of a 
(perceived [4,5]) vasovagal reaction.  Vasovagal reactions include faintness, dizziness, 
nausea, decrease in blood pressure, chest pain, convulsions or loss of consciousness.  Donors 
who self-report feeling faint, dizzy, weak, and/or lightheaded from donating blood are 
retained at a lower rate than those who do not [4,5]. 
 
The last type of negative event is a service failure where the donor’s expectations regarding 
the donation experience are not met. For example, donors who perceive long waiting times 
are less satisfied and are less likely to return [6, 7-9]. Physical injuries are also a service 
failure and arm or needle related injuries (bruising, soreness) and fatigue negatively impact 
donor retention. However, overall, their impact on retention is generally weaker than that 
observed from vasovagal reactions [10-13]. 
 
All of these negative events can discourage donor return. However, what is unknown is 
which type of negative event has the strongest effect on donor turnover when they are 
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considered jointly. Further, to date, donor retention following a negative event has typically 
only been explored within panel; that is, whether WB donors return to donate WB again. 
Whether the deterrence effect generalizes to other forms of donation (e.g., plasmapheresis), 
or whether the request for something different or being early career in a new type of donation 
(i.e., plasmapheresis) is sufficient to motivate return [14] is unknown. It is possible that 
donors perceive sufficient differences between donation types such that negative beliefs 
resulting from WB donation do not generalize to deter alternative forms of donation [15]. 
Further, as donors typically hold positive beliefs about the general value of donating (e.g., to 
save lives) that motivate all forms of blood product donation [16] negative events may not 
deter donors from converting to a new donation experience. 
 
Potential moderators.  While negative events deter first-time [17,18] and experienced [10] 
donors alike, there are mixed results as to which cohort is more strongly affected.  Some 
report that the negative effect of a deferral on retention is weaker among more experienced 
donors [1-3].  However, France and colleagues [19] found that the return rate of experienced 
donors was 13% lower than for first-time donors who had experienced the same magnitude of 
vasovagal reaction.  
 
The current study 
In this study, we focus on the impact of negative experiences during, and deferrals following, 
a donor’s most recent donation on the conversion of WB donors to plasmapheresis and 
retention of first-time plasmapheresis donors. We investigate the impact of officially 
recorded vasovagal reactions along with donors’ subjective assessments of issues arising in 
their donation and application of a deferral. Further, given the mixed results on the role of 
donation experience in mitigating the effects of negative events on retention, we also explore 
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the role of WB donation history on plasmapheresis conversion and retention.  Our primary 
focus is on subsequent plasmapheresis donation behavior.  However, in the context of 
plasmapheresis, the impact of negative experiences on behavior is likely mediated by donor 
intention.  Specifically, while negative experiences may impact the motivation of the donor to 
present to donate, this motivation is not the sole determinant of donation behavior; not all 
donors are seen as suitable or desirable for (continued) plasmapheresis by BCAs [14].  
 
Method 
Participants and Procedure 
The final conversion sample of current WB donors was 894 participants, 51.2% were male, 
with a modal age range of 20-30 years (M = 40.30 years, SD=12.85).  Our sample matched 
the broader WB panel in modal age range, but with males marginally overrepresented (51.2% 
vs. 48%).  WB donor participants had made an average of 5.49 (SD=5.13) WB donations in 
the prior five years with 12% completing their first WB donation at our first point of data 
collection (T1). The final retention sample of those who had made their first plasma donation 
at T1 was 954 participants, 48.8% were male, with a modal age range of 20-30 years (M = 
40.04 years, SD=13.17).  Similar to the conversion sample, our sample matched the modal 
age of the first-time plasmapheresis panel.  However males were marginally 
underrepresented in comparison to the broader panel (48.8% vs. 54%).  Prior to conversion, 
plasmapheresis donor participants had made an average of 5.22 (SD=4.56) WB donations in 
the prior five years, with 21% completing only one WB donation prior to their 
plasmapheresis donation at T1.  
 
A survey package including a personalized letter, survey, and facilitators of pen and teabags 
were distributed to eligible participants over an eight-week period with reminder post cards 
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sent two weeks later to non-responders. Completed surveys were excluded if the respondent: 
(1) indicated that they had been exposed to a targeted conversion campaign trialed by the 
BCA during part of the data collection period1, or (2) had been sent a survey package in error, 
or (3) had completed one (in the conversion sample) or more than one (in the retention 
sample) apheresis (plasma or platelet) donation. Participants were also excluded if they had 
not successfully completed their index (T1) donation and if any applied deferral did not allow 
a minimum of 30 days between T1 (the index donation) and T2 (the end of the observation 
period) to make a plasmapheresis donation. 
 
Survey packages were sent to 1,957 donors across 18 Donor Centers between 0-10 days 
(M=2.17, SD=1.43) of making a WB donation (i.e., T1), with 993 donors returning their 
surveys (giving 51% response rate before screening). In line with the then standard practice 
of the BCA, each participant had discussed the possibility of making a plasmapheresis 
donation with Donor Center staff.   The same survey package was sent to 1,708 donors from 
78 Donor Centers between 2-15 days (M=3.56, SD=1.59) after successfully completing a first 
plasmapheresis donation (i.e., T1) with 1,076 donors returning the surveys (giving a 63% 
response rate before screening).  
 
Measures 
Three types of negative events were assessed: deferral applied captured from BCA national 
records, vasovagal reactions recorded by the BCA staff and donor’s self-report of their 
donation experience.  While 99 different deferral codes were applied, the majority related to 
malaria (57%) and medication (non-steroidal anti-inflammatory or aspirin, 12%).  
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Vasovagal reactions were recorded within one week of the T1 donation and deferrals codes 
applied at T1 were captured through usual BCA practices. Vasovagal reactions were 
categorized as mild (vasovagal symptoms for <15 minutes without fainting [20]; WB n=9, 
Plasma n=25), moderate (vasovagal symptoms for 15-60 minutes without fainting; WB n=3, 
Plasma n=9), or severe (faints or experiences vasovagal symptoms without fainting for >1 
hour; WB n=0, Plasma n=7) or other adverse event (WB n=1, Plasma n=7). Due to small 
numbers, these were combined and a total vasovagal score was used.  Last, self-reported 
negative experiences were measured by asking respondents “Did you experience any 
problems or difficulties with the donation?” and if yes, “What problems or difficulties did 
you experience?”.  Answers to this question were subsequently coded into three categories: 
physical (e.g., felt faint, hot, had nausea, needle pain or discomfort); psychological (e.g., 
stress, anxiety, concern re needles, fear of germs through return process); or logistical (e.g., 
process took much longer than expected, not sufficiently prepared, administrative delay) 
issues.  
 
As part of a larger study2, plasmapheresis donation intentions were assessed. Participants 
reported their intentions to make a first (for WB donors) or another (for plasma donors) 
plasmapheresis donation. Item stems were: “I intend to …”, “I will try to …” and “I will …” 
with a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree; scale reliability: = 
.97 for WB donors and .91 for plasma donors). WB donation history for the previous five 
years to T1 donation was obtained from BCA national records as was any plasmapheresis 
donation within the four to six month period (M=159.93 days, SD=16.06 days) between T1 
and T2. Plasmapheresis donation behavior was coded as 1 (yes) or 0 (no) to making a first 
(WB sample) or another (plasma sample) plasmapheresis donation.   Between T1 and T2, 199 
(23%) WB donors and 515 (54%) plasmapheresis donors donated plasma.  
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Statistical analyses 
Means, standard deviation, bivariate correlations, and group comparisons (t-tests, chi square) 
were calculated using SPSS 19.0 [21]. Path analyses (MPlus 7.11 [22]) were conducted 
controlling for the variability in the number of days between T1 and T2 for each participant. 
Due to the dichotomous dependent variable, a robust weighted least-squares estimator with 
mean- and variance-adjusted chi-square statistic was used. Model fit indices cut-offs used 
included, a comparative fit index (CFI) above 0.95, a root mean square error of 
approximation (RMSEA) of less than 0.06, and a weighted root mean square residual 
(WRMR) below 0.90. 
Results 
 
Issues with last (T1) donation 
Regarding the donation given at T1, 47.6% of first-time plasma donors experienced some 
form of negative event (deferral, vasovagal reaction or self-report) compared to 31.9% of (the 
more experienced) WB donors. The majority of the plasmapheresis (78%) and WB donors 
(85%) only had one type of negative event although some donors reported all three types of 
negative events (n=17, 3.7% plasmapheresis and n=1, 0.4% WB). 
 
Self-reported donation negative experiences and their timing are summarized in Table 1. For 
both WB and plasmapheresis donations, physical issues were predominately experienced 
during donation. Logistical issues impacted on WB donors across the donation process, but 
predominantly before the donation. However, for plasmapheresis donors, logistical issues 
were equally likely to be reported before and during the donation. Plasmapheresis is a longer 
service encounter than WB donation and this has been noted as a key deterrent to conversion 
[15]. Thus, it is perhaps unsurprising that the recall of logistical issues (including the 
donation/process taking longer than expected) was higher in the plasmapheresis than the WB 
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sample. For both samples, donors who described multiple negative experiences (e.g., physical 
and logistical) reported these as occurring during donation. 
 
An analysis of negative events by prior WB donation experience (first-time or more 
experienced) and by gender shows a number of differences in both the conversion (Table 2) 
and retention (Table 3) samples. Within the WB conversion sample, and contrary to previous 
research [19,23,24], the self-report of any issue with donation or recorded vasovagal reaction 
did not vary as a function of donor experience. However, consistent with previous studies 
[19,24, cf 23] female donors were more likely to have vasovagal reactions recorded than 
male donors and experience physical and logistical difficulties. In addition, first-time donors 
were more likely to be deferred than experienced donors [25-26], but this did not differ by 
gender. 
 
Similarly, within the plasmapheresis sample (Table 3), the self-report of any negative 
experience associated with a first plasmapheresis donation did not vary as a function of WB 
donation experience. Further, female donors were more likely to report experiencing physical 
difficulties (and recorded vasovagal reactions) than male donors; however, unlike WB 
donors, there were no gender differences in reporting logistical issues. More experienced WB 
donors were less likely to have a recorded vasovagal reaction than those donors who 
converted after a single WB donation. Deferrals for first-time plasmapheresis donors did not 
differ as a function of prior WB donation experience or gender. 
 
Prior to modeling the effects of negative events on subsequent donation intentions and 
behavior, the association between all variables was assessed (Table 4). In both the conversion 
and retention samples, intention to make a (subsequent) plasmapheresis donation was 
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significantly positively related to subsequent plasmapheresis donation. WB donation history 
was significantly negatively associated with, and deferral significantly positively associated 
with, intention to convert to plasmapheresis for current WB donors. Physical, psychological, 
vasovagal reaction and deferral, in addition to WB history, were significantly negatively 
associated with intention to be retained in the plasmapheresis panel. In both the WB and 
plasmapheresis samples, the self-report of physical issues with donation was significantly 
positively correlated with recorded vasovagal reactions. 
 
To explore the potential differential effect of donors’ self-reported physical and logistical 
issues3 with donation, recorded vasovagal reactions, and deferral as a function of WB 
donation history, moderated analyses were conducted.  Acceptable model fit indices were 
achieved for both samples (Table 5). For the WB sample, intention to convert to 
plasmapheresis was significantly positively associated with subsequent conversion (β = .72, p 
< .001). Of the predictors, only WB donation history (β = -.23, p < .001) and gender (β = .10, 
p<.01) were significantly associated with intention. Those with a higher number of WB 
donations in the past 5 years and women were less likely to intend to convert to plasma. Prior 
WB donation history did not moderate the relationship between donation issues and 
conversion intentions4.  
 
As with the WB sample, the relationship between intention to remain within the 
plasmapheresis panel and subsequent plasmapheresis behavior was significant and positive 
(= .33, p = .001). Having a recorded vasovagal reaction with ( = -.18, p < .001), or a 
deferral applied after, the first plasmapheresis donation ( = -.12, p < .05) were significantly 
negatively associated with intention to remain in the plasmapheresis panel. No other 
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predictors were significantly associated with intention. Prior WB donation history did not 
moderate the relationship between negative events and conversion intentions. 
 
Discussion 
This study extends the current empirical literature on the impact of negative events on 
donation behavior.  Our results, from donors who self-selected to participate, indicate that 
subjective negative physical, psychological, and logistical experiences with donation do not 
consistently impact subsequent plasmapheresis intentions and behavior. Deferrals and the 
experience of an officially recorded vasovagal reaction decrease first-time plasmapheresis 
donors’ intentions to remain within the plasma panel.  However, these same factors do not 
significantly impact WB donors’ intentions to convert to plasmapheresis.   Further, the 
impact of vasovagal reactions and deferrals on retention is not moderated by WB donation 
experience. 
 
While donors can identify a range of subjective physical, psychological, and logistical issues 
around donating, these subjective experiences may not, in and of themselves, consistently 
deter conversion or retention to plasma (with the exception of psychological issues and 
plasmapheresis retention3). This lack of impact of self-reported physical issues contrasts with 
a significant body of research that has consistently shown that subjective negative physical 
reactions to donation decrease retention [4,19,27,28-33]. While smaller effects of some 
service experience injuries (e.g., bruising, sore arm [11-13,27]) on retention have been 
observed, the relationship between more severe physical reactions and retention is considered 
robust [4,10,19,34-37].  
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Why the results of the current analysis differ from those obtained in past analyses is not 
immediately clear. However, the prevalence of physical reactions recorded by participants (< 
10% of WB donors and 15% of first-time plasma donors) was notably lower than recorded in 
prior Australian analyses [33].  One possibility is that the change to a qualitative method of 
elicitation from the typical structured quantitative method (e.g., BDRI [4,5]) resulted in the 
differences observed. However, it may be expected that the open-ended question of “Did you 
experience any problems or difficulties with the donation?” would result in more rather than 
less issues being noted than a quantitative method that specifies the types of issues that a 
donor may experience.  
 
Alternatively, our sampling of only those donors who successfully completed a donation at 
T1, the timing of our survey, and the wording of the stimulus question may have 
unintentionally led to an underreporting of negative events. In the current analysis, the 
sample comprised those who had recently successfully completed a donation. This contrasts 
with other analyses [33] in which all donors who attempted a donation were recruited. 
Further, donors can experience heightened post donation positive affect [38-40].  In this 
context, our question that focused on the successful outcome of the process (i.e., a donation, 
not merely a donation attempt) may have led to donors to positively reflect on their 
experience and discount any minor negative experiences. As such, the prevalence rates 
indicated in the current analysis may represent an underreporting of subjective negative 
experiences. Consistent with France and colleagues [41], this suggests that sampling all 
donors (including those who do not complete a full donation) using a consistent quantitative 
‘real-time’ approach to assessing their subjective experiences is optimal. 
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Despite the potential problems observed with the qualitative method of elicitation, donors’ 
self-reports of physical problems were significantly positively associated with officially 
recorded vasovagal reactions [5]. Within the conversion sample, those who had given fewer 
WB donations were more likely to convert.  However, within the plasmapheresis panel, 
vasovagal reactions were significantly more likely to occur among those who had converted 
to plasma having given only a single WB donation. Consistent with prior studies, the 
experience of a vasovagal reaction during donation deterred plasmapheresis donors from 
returning, an effect not qualified by donor experience (cf. [19]).  
 
Alongside vasovagal reactions, deferrals emerged as another interesting predictor.  While 
deferrals deterred plasmapheresis retention, the application of a deferral did not deter WB 
donors from forming the intention to convert to plasmapheresis. Contrary to previous within-
panel analyses [1-3], these effects were not moderated by donor WB experience. Although 
deterrence of the same type of donation behavior may seem logical, it is particularly 
interesting as the majority of deferrals applied (for malaria or non-steroid anti-inflammation 
medication) were short-term and not universal to all donation behavior [3]. Consequently, 
many deferred donors were eligible to continue donating during the study period [42].  
Further, the intention to donate assessed was not temporally bound. As such, the results 
suggest deferrals promote within panel attrition [2-5, 12]. Why this occurs is not clear. One 
possibility is that donors do not understand BCA information on their deferral [3]. 
Alternatively, a deferral may leave the donor feeling rejected [43-45] or dissatisfied [46]. 
While empathetic counseling may overcome this [47], the current data suggest that these 
feelings may be mitigated by the offer to do something different (i.e., convert to 
plasmapheresis) and to continue to help others [48]. Future research should consider how the 
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communication of deferrals can be improved to ensure long-term retention, particularly for 
those for whom conversion to an alternative form of donation is not appropriate. 
 
Overall, the results suggest that vasovagal reactions and deferrals may not universally deter 
donors from engaging with a BCA. Rather, the offer to convert to another form of donation – 
in this instance, plasmapheresis – was sufficient to eliminate the negative effect of these 
factors on retention. In our analysis, intention predicted behavior and the intention to convert 
to plasmapheresis was only negatively associated with WB donation history and gender.  
Women were less likely to intend to convert, perhaps through being less strongly encouraged 
[49] and those with more prior WB donations were less likely to intend to convert. However, 
alongside those deferred, first-time WB donors who convert to plasmapheresis also require 
special care. Although first-time donors are ‘easier’ to convert – perhaps because their 
‘script’ as to which behaviors are encompassed within their identity of being a donor is still 
developing [50] – their vasovagal reaction rate to plasmapheresis is higher than more 
experienced donors [51]. Within this panel, vasovagal reactions deterred all donors from 
returning. Longer-term retention will require determining the optimal number of prior WB 
donations before attempting conversion to minimize the risk of vasovagal reactions during 
plasmapheresis donation while ensuring receptivity to conversion practices. 
 
While future research should evaluate this proposed trajectory through tracking a cohort of 
first-time donors through conversion to (potential) negative events during and after 
plasmapheresis, it also suggests attention should be focused on early career donors who are 
converted. Although a range of successful interventions have been developed for vasovagal 
reactions in WB donors [52], there are few interventions for reactions to plasmapheresis. The 
mid-donation infusion of saline used in Australia, (http://www.blood.gov.au/pubs/2013-
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haemovigilance/section7.html) may not be acceptable to all due to the hemodilution of 
plasma proteins that occurs with this infusion [53].  As such, more research is needed to 
determine how to minimize vasovagal reactions in plasmapheresis donors. Research suggests 
that plasmapheresis may be anxiety provoking [15] and, as such, interventions targeting 
anxiety and building self-efficacy [54-58] may be useful.  
 
Conclusions 
This study provides a unique insight into how vasovagal reactions and deferrals may not 
universally deter donors from ongoing engagement with BCAs. Similar to allowing deferred 
donors to donate for research to maintain engagement with the BCA [43], the current analysis 
shows that ‘asking for something different’ – in this case plasma – is sufficient to mitigate the 
negative effect of vasovagal reactions and deferrals on future donation behavior. However, 
future research should replicate this effect and seek to determine how retention is maintained. 
Such a replication should use a standardized measure of donors’ experiences (e.g., the BDRI 
[4,5]) and a longitudinal design to consider the experiences of first-time WB donors who 
convert to plasmapheresis and then potentially experience a negative event. Within the 
current analysis, the percentage of variance accounted for in the outcome variables was small 
in both samples. Measuring other factors known to impact the decision-making process 
would help determine whether the effects of negative events on plasmapheresis donation can 
be outweighed. These limitations of the current analysis aside, the results of this study assists 
BCAs in two ongoing challenges: how to retain active donors and, for those BCAs committed 
to VNR plasmapheresis, how to optimize recruitment to plasmapheresis. 
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Endnotes 
1 Due to operational needs the BCA ran a targeted plasmapheresis campaign for two weeks 
while data collection was ongoing.  This campaign was in addition to the business as usual 
practice of Center staff approaching donors to ask them to convert to plasmapheresis.  Due to 
the short duration of this campaign, and our successful attempt to isolate participants from 
exposure to it, the numbers of donors in our sample exposed were small (n=15 WB sample; 
n=29 plasmapheresis sample). As such, campaign exposure could not be considered as an 
additional factor in analyses and so the responses of donors exposed were excluded to ensure 
consistency of conversion/retention practices across our samples.  
2  The larger study assessed multiple aspects of the donor experience that were thought likely 
to impact donors’ plasmapheresis intentions and behavior – for example service interactions 
with BCA staff, loyalty to the BCA and pride in being a donor.  In addition, donors were 
asked to respond to questions designed to assess their exposure to a targeted plasmapheresis 
campaign (see endnote 1).     Surveys were also administered to a broad range of donors, 
including those who had not engaged with the BCA for a period of time.  
3 Psychological self-report issues were dropped from analyses due to small numbers (i.e., one 
WB donor reported) and to maintain predictors constant across both samples. With 
psychological issues included in the plasmapheresis sample (n=6 reported), the model retains 
good fit to the data (2(13)=12.24, p=0.51, CFI=1.000, RMSEA=0.000, WRMR=0.61) with 
psychological issues a significant negative predictor (β =-.07, p=.01) of retention intentions. 
Vasovagal reactions and deferrals remain the only other significant predictors.  
4Among those WB donors who did not convert to plasmapheresis, preliminary analyses were 
conducted to explore whether WB panel retention could be predicted. However, due to small 
numbers, there was a violation of the assumptions underpinning the planned moderated 
logistic regressions and so these analyses were abandoned. 	
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Table 1 
 
Self-report issue by type and timing for both samples 
 
Issue 
Whole Blood 
116 participants (13.0%)  
reporting 133 issues 
Plasma  
174 participants (18.2%) 
reporting 233 issues 
Before During After 
Not 
clear 
Before During After 
Not 
clear 
Physical 0% 7.9% 
(71) 
1.8% 
(16) 
0.2% 
(2) 
0% 12.1% 
(115) 
3.0% 
(29) 
0.0% 
(0) 
Psychological 0% 0% 0% 0.1% 
(1) 
0% 0.6% 
(6) 
0% 0.0% 
(0) 
Logistical 1.8% 
(16) 
0.6% 
(5) 
0.4% 
(4) 
6.7% 
(6) 
2.5% 
(24) 
2.5% 
(24) 
0% 0.1% 
(1) 
Multiple 0% 0.4% 
(4) 
0% 0.2% 
(2) 
0% 1.5% 
(14) 
0% 0.3% 
(3) 
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Note: Non-mutually exclusive variables included in models; that is, participant reporting physical and logistical issue included in both variables. 
Not clear = timing when issue occurred not clear. 
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Table 2 
Frequency of whole blood (WB) donors who indicated a problem at donation by type and by donation experience and gender 
Type of Donation Issue 
WB Donor 
sample 
Donation Experience Gender 
TOTAL 
N(%) 
WB=1 WB>1 Significantly different? Male Female Significantly different? 
        
Self-report issue 116 (13.0%) 13.5% 12.9% 2(1, N=894)=0.03, p=.88 8.7% 17.3% 2(1, N=892)=14.50, p<.001 
 76.7% Physical 89 (10.0%) 12.5% 9.6% 2(1, N=894)=0.85, p=.36 6.8% 13.4% 2(1, N=892)=10.79, p=.001 
0.1% Psychological 1 (0.1%) 0% 0.1% N/A 0% 0.2% N/A
26.7% Logistical 31 (3.5%) 1.0% 3.8% 2(1, N=894)=2.21, p=.14 1.7% 5.1% 2(1, N=892)=7.57, p=.01 
        
AE within week 13 (1.5%) 2.9% 1.3% N/A 0.7% 2.3% 2(1, N=892)=4.22, p=.04 
      
Deferral applied at T1 200 (22.4%) 54.8% 18.1% 2(1, N=894)=71.30, p<.001 22.7% 22.2% 2(1, N=892)=.044, p=.83 
        
      
Note: N/A = cell less than expected cell count. CIs = confidence intervals. 
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Table 3 
Frequency of first-time plasma donors who indicated a problem at donation by type and by donation experience and sex 
Type of Donation Issue 
1st time 
plasma donor 
sample 
Donation Experience Gender 
TOTAL 
N(%) 
WB=1 WB>1 Significantly different? Male Female Significantly different? 
        
Self-report issue# 174 (18.2%) 16.8% 18.6% 2(1, N=954)=0.37, p=.54 16.1% 20.4% 2(1, N=951)=2.96, p=.09 
79% Physical 137 (14.4%) 14.7% 14.3% 2(1, N=954)=0.03, p=.87 11.8% 16.9% 2(1, N=951)=5.02, p=.03 
3% Psychological 6 (0.6%) 0% 0.8% N/A 0.2% 1.0% N/A
28% Logistical 49 (5.1%) 3.0% 5.7% 2(1, N=954)=2.23, p=.14 6.0% 4.3% 2(1, N=951)=1.37, p=.24 
        
AE within week 38 (4.0%) 7.1% 3.2% 2(1, N=954)=6.33, p=.01 2.4% 5.6% 2(1, N=951)=6.37, p=.01 
        
Deferral applied at T1 359 (37.6%) 39.6% 37.1% 2(1, N=954)=.41, p=.52 37.3% 37.9% 2(1, N=951)=0.04, p=.85 
        
      
Note: #breakdown of self-report not mutually exclusive, therefore totals > 174. N/A = not conducted as cell counts less than 5. CIs = confidence 
intervals. 
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Table 4 
Correlations for variables for WB conversion (lower) and plasma retention (upper) sample 
 Variable 1 2 3 4 5 6 7 8 9 
           
1 Plasma Donation - .28** -.13** -.11** -.06 -.05 -.12** -.09** .04 
2 Intention .47** - -.17** -.16** -.10** -.03 -.20** -.15** -.09** 
3 Self-report total# -.05  -.04 - .87** .17** .49** .39** .09** -.03 
4 #Physical -.03 -.05 .86** - .12** .09** .44** .11** -.04 
5 #Psychological -.02 -.02 .09** -.01 - .04 .11** .08* -.01 
6 #Logistical -.04  -.00 .49** .04 .18** - .00 -.01 .06 
7 AE -.02  -.01 .23** .27** -.00 -.02 - .04 -.10** 
8 Deferral .02  .10** .05 .00 -.02 .07* .00 - .04 
9 WB History -.06 -.29** -.01 -.01 -.03 .01 -.08* -.15** - 
           
Note: #Self-report total (variable 3) comprises physical, psychological and logistical (variables 4-6 respectively) issues reported. * p<.05, 
**p<.01, ***p<.001 
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Table 5 
Standardized path coefficients for the WB and plasma sample with donation issues 
moderated by WB history 
 
Whole Blood
)=17.221, p=0.1415, 
RMSEA=0.022 (90% CIs 0.000, 
0.044), CFI=0.979, 
WRMR=0.675

Plasma
)=11.918, p=0.4523, 
RMSEA=0.000 (90% CIs 0.000, 
0.033), CFI=1.000, WRMR=0.625

Path / Predictor  SE  SE 
Behavior  R2 = .53 R2 =.12 
Intention    
Behavior period (control)    
Intention  R2 =.10 R2 =.09 
Physical issue self-report    
Logistical issue self-report    
Adverse Event within week    
Deferral applied at T1    
WB History for 5 years    
Physical x History    
Logistical x History    
Adverse Event x History    
Deferral x History    
Gender    
Age    
Note: Psychological issues not included due to low numbers. * p=.05, **p<.01, ***p<.001 
 
